ORASURE TECHNOLOGIES, INC Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
ORASURE TECHNOLOGIES, INC (OSUR) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $3.24 million as of 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-09
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.24M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.30M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.47M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.03M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $3.24M 10-K · filed 2026-03-09 |
| 2024-12-31 | $3.30M 10-K · filed 2026-03-09 |
| 2023-12-31 | $3.47M 10-K · filed 2025-03-07 |
| 2022-12-31 | $3.03M 10-K · filed 2024-03-11 |
| 2021-12-31 | $1.89M 10-K · filed 2023-03-03 |
| 2020-12-31 | $1.35M 10-K · filed 2022-03-01 |
| 2019-12-31 | $1.78M 10-K · filed 2021-03-01 |
| 2018-12-31 | $1.25M 10-K · filed 2020-03-02 |
| 2017-12-31 | $976.00K 10-K · filed 2019-02-28 |
| 2016-12-31 | $6.11M 10-K · filed 2018-02-28 |
| 2015-12-31 | $6.37M 10-K · filed 2017-03-14 |
| 2014-12-31 | $5.37M 10-K · filed 2016-03-14 |
| 2013-12-31 | $4.70M 10-K · filed 2015-03-12 |
| 2012-12-31 | $4.18M 10-K · filed 2014-03-14 |
| 2011-12-31 | $4.16M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |